# Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma

> **NCT04047693** · PHASE2 · UNKNOWN · sponsor: **Pusan National University Yangsan Hospital** · enrollment: 32 (estimated)

## Conditions studied

- Muscle Invasive Bladder Cancer
- Urothelial Carcinoma
- Neoadjuvant Chemotherapy

## Interventions

- **DRUG:** dose dense MVAC with pegylated GCSF

## Key facts

- **NCT ID:** NCT04047693
- **Lead sponsor:** Pusan National University Yangsan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-01
- **Primary completion:** 2022-01-31
- **Final completion:** 2022-10-31
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2022-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04047693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04047693, "Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04047693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*